Last Price
1.57
Today's Change
-0.76 (32.61%)
Day's Change
1.26 - 2.19
Trading Volume
1,354,158
Exchange: NASDAQ Global Market NASDAQ Global Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Mr. Tomer Izraeli Mr. Tomer Izraeli
Full Time Employees: 1 1
IPO Date: 2024-10-29 2024-10-29
ISIN: IL0011814113 IL0011814113
Beta: 0.00 0.00
Last Dividend: 0.00 0.00
Dcf Diff: 0.00 0.00
Dcf: 0.00 0.00
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company's nasal sprays provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. It develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza. The company was incorporated in 2005 is headquartered in Ra'anana, Israel.